The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, and will help health professionals navigate a treatment landscape that has ...
Credit Karolina Grabowska via PexelsThe first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been ...
Despite major advances in artificial intelligence (AI) research for healthcare, the deployment and adoption of AI technologies remain limited in clinical practice. This paper describes the FUTURE-AI ...
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, and will help health ...
Clinical guidelines for primary prevention of type 2 diabetes in Southeast Asia emphasize screening, diagnosis, and ...
On January 7, 2025, the U.S. Food and Drug Administration (“FDA” or “Agency”) released a long-awaited guidance titled, “Communications From Firms ...
The remote patient monitoring (RPM) technology that a patient uses while receiving hospital-at-home care does not follow a ...
A new systematic review and meta-analysis published in the Clinical Nutrition ESPEN revealed promising outcomes for the ...
William Dale, MD, PhD, FASCO, highlighted the shift from the first geriatric oncology guidelines made in 2018 to the ...
We continue our New Jersey Regulatory Update with this Part II, which focuses on regulations that were finalized in the second half of 2024 and ...
Verywell Health on MSN2d
Is There Really That Big of a Difference Between Magnesium Glycinate and Citrate?Magnesium glycinate and citrate are two common forms of magnesium supplements. Learn the differences between them and when ...
The study found that serum polychlorinated biphenyls independently increased the risk of incident cardiovascular disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback